Tert-butyl 3-aminoazetidine-1-carboxylate → HCID 25254000, compound

HRID 1880880Notes

Reaction equation

HRID 1880880 reaction equation
[CH:1]1([N:7]2[CH2:13][C:12]([F:15])([F:14])[C:11](=[O:16])[N:10]([CH3:17])[C:9]3[CH:18]=[N:19][C:20]([NH:22][C:23]4[CH:31]=[CH:30][C:26]([C:27](O)=[O:28])=[CH:25][C:24]=4[O:32][CH3:33])=[N:21][C:8]2=3)[CH2:6][CH2:5][CH2:4][CH2:3][CH2:2]1.CN(C(ON1N=[N:49][C:44]2C=C[CH:47]=[N:48][C:43]1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F.C(N1CC(N)C1)(OC(C)(C)C)=O>>[NH:48]1[CH2:43][CH:44]([NH:49][C:27](=[O:28])[C:26]2[CH:30]=[CH:31][C:23]([NH:22][C:20]3[N:19]=[CH:18][C:9]4[N:10]([CH3:17])[C:11](=[O:16])[C:12]([F:14])([F:15])[CH2:13][N:7]([CH:1]5[CH2:6][CH2:5][CH2:4][CH2:3][CH2:2]5)[C:8]=4[N:21]=3)=[C:24]([O:32][CH3:33])[CH:25]=2)[CH2:47]1

Participants

4

Procedure

The title compound was synthesized from 4-(9-cyclohexyl-7,7-difluoro-5-methyl-6-oxo-6,7,8,9-tetrahydro-5H-pyrimido[5,4-b][1,4]diazepin-2-ylamino)-3-methoxybenzoic acid as described in the General procedure for amide bond synthesis using HATU and 1-N—Boc 3-amino azetidine. The final compound was purified by reverse phase HPLC and basified to give the free base. Further, after washing with water (10 ml), t-butoxycarbonyl (Boc) protection group was removed using 40% TFA in dichloromethane (6 ml) and the final compound was purified by reverse phase HPLC and basified to give the free base. 1H NMR (400 MHz, DMSO-d6) δ ppm 1.13-1.28 (m, 1 H) 1.33-1.46 (m, 2 H) 1.59-1.66 (m, 2 H) 1.75-1.87 (m, 4 H) 3.32 (s, 3 H) 3.67-3.80 (m, 4 H) 3.95 (s, 3 H) 4.07 (t, 2 H) 4.4-4.5 (m, 1 H) 4.65-4.83 (m, 1 H) 7.50 (d, J=8.3 Hz, 1 H) 7.54 (d, J=1.5 Hz, 1 H) 7.93 (s, 1 H) 8.21 (s, 1 H) 8.29 (d, J=8.1 Hz, 1 H) 8.81 (d, J=6.8 Hz, 1 H). [M+H] calc'd for C25H31F2N7O3 516; found 516.

Workup

  1. customas described in the General procedure for amide bond synthesis
  2. customThe final compound was purified by reverse phase HPLC
  3. customto give the free base
  4. washFurther, after washing with water (10 ml), t-butoxycarbonyl (Boc) protection group
  5. customwas removed
  6. customthe final compound was purified by reverse phase HPLC
  7. customto give the free base

Sources & evidence

ORD record
ord-ed08d6f429ed4d3b8643de876dc0ff31
Source dataset
uspto-grants-2012_11
Patent number
US08318727B2

Reaction notes

Loading…